Clinical Trials Browser

Phase 2 × Terminated × poly ICLC × Clear all

NCT01437605 2019-12-20

Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC

Phase 2 Terminated

14 enrolled 9 charts

Melanoma

NCT00052715 2018-07-18

Poly-ICLC

Phase 2 Terminated

31 enrolled 8 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma